poster

TV-46000—a Long-Acting Subcutaneous Antipsychotic (LASCA) for the Treatment of Schizophrenia: Local Tolerability and Injection Site Reactions

TV-46000 is a long-acting subcutaneous antipsychotic (LASCA) that combines risperidone and an innovative delivery technology in a suspension suitable for subcutaneous administration in th...

Kelli R. Franzenburg , PhD;

10/26/2023

Understanding Patient Profiles among Medicaid Patients with Treatment-resistant Depression Initiated on Esketamine

Real-world data studies on esketamine use for treatment-resistant depression (TRD) in the US have previously focused on commercially-insured patients. In this study of Medicaid beneficiar...

Kruti Joshi , MPH, MD;

10/26/2023

Understanding Profiles of Patients with Treatment-resistant Depression by Stringency of Health Plan Prior Authorization Criteria for Approval of Esketamine

In the United States, some health plans have more stringent prior authorization (PA) criteria for esketamine insurance coverage for treatment-resistant depression (TRD), requiring more th...

Kruti Joshi , MPH, MD;

10/26/2023

Understanding the Experiences of Patients With Major Depressive Disorder Treated With Zuranolone: Qualitative Interviews With Participants From the Open-Label SHORELINE Study

Researchers conducted qualitative interviews to understand patients’ experiences with and perceptions of zuranolone, an oral, investigational, once-daily, 14-day treatment course in clini...

Amanda McDaniel ;

10/26/2023

Understanding the Independent Impact of Social Determinants of Health on Resource Utilization and Health Outcomes in Civilian Post-Traumatic Stress Disorder: A Real-World Evidence Analysis

This study assesses the independent impact of social determinants of health and presence of post-traumatic stress disorder on resource utilization and health outcomes in civilians with po...

Jyoti Aggarwal , MHS;

10/26/2023

Treatment Patterns From OASIS: Observational Study of Long-Acting Injectables in Schizophrenia

OASIS was a 12-month observational study evaluating real-world outcomes of atypical long-acting injectable (aLAI) antipsychotics in patients with schizophrenia. Most patients initiated aL...

Dawn Velligan , PhD;

10/26/2023

The Relationship Between Therapist Adverse Childhood Experiences, Personal Therapy, Resilience, and Treatment Outcomes

A dissertation exploring the relationships between therapist adverse childhood experiences, personal therapy, resilience, therapeutic alliance, and treatment outcomes.

Elizabeth Nunez , PsyD;

10/26/2023

The Role of Emotion Dysregulation and Pain-endurance in Non-suicidal Self-injury and Disordered Eating Behaviors

This poster shows the interactive relationship between physical pain endurance and emotion dysregulation as predictors for risky behaviors such as NSSI and disordered eating/exercising. ...

Caroline M. Johnson , BA;

10/26/2023

The Use Of The Socially Assistive Robot (SAR) “Pepper” In Prevention And Treatment Of Psychiatric Diseases – Project Descriptions

The poster gives an overview of two projects dealing with the use of new technologies in the prevention and treatment of psychiatric diseases, which will be conducted at the Medical Unive...

Alfred Haussl , MSc, BScN;

10/26/2023

Time Dynamics of Adverse Events of Interest Occurring with Esketamine Nasal Spray and Quetiapine Extended Release: Results from the ESCAPE‑TRD Phase IIIb Trial

This safety analysis evaluated the duration of treatment-emergent adverse events (TEAEs) reported for esketamine nasal spray (ESK-NS) versus quetiapine extended release (QTP-XR) in patien...

Hannah Bowrey , PhD;

10/26/2023

Tracks

Major Depressive Disorder

General Psychiatry

ADHD

MDD Insights

Schizophrenia Insights

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.